MYOMO, INC. (MYO) is a leading medical robotics company based in the United States. The company is primarily known for its innovative wearable robotics and orthotics, designed to enable users to overcome mobility constraints associated with various neurological disorders and injuries.
Established in 2004, MYOMO, INC. operates with the vision to improve the lives of individuals with neuromuscular disorders, facilitating their independence by offering innovative robotics solutions. The name 'MYOMO' is actually an acronym for "My Own Motion," aptly reflecting the firm's mission to aid people in reclaiming their mobility and effectively carrying out routine activities.
MYOMO's flagship product is the MyoPro©, a robotic arm brace that augments muscle strength in users affected by muscle weakness or paralysis due to stroke, traumatic injury, or neuro-muscular disease such as Multiple Sclerosis or ALS. This life-changing technology, licensed from the Massachusetts Institute of Technology (MIT), is the only one of its kind in the marketplace.
Critically, the MyoPro© is not just a mobility aid – it is a powered brace that can actually enable the user to regain the ability to conduct tasks that they may not have been able to do since their injury or diagnosis. The device is customizable to each individual user and is designed to interpret faint nerve signals and enable controlled, functional movement.
MYOMO continues to lead in its field by combining intensive customer feedback, cutting-edge engineering, and a human-first approach. This method has enabled MYO to secure coverage for its MyoPro© line of products within numerous insurance providers, including Medicare and top private insurance carriers, making these critical mobility solutions more accessible to those in need.
MYOMO, INC. is more than just a company that sells products. It has goals that are deeply rooted in improving people's lives by aiding their physical mobility. Its commitment to excellence and innovative solutions has placed the company at the forefront of medical robotic technology, helping countless individuals reclaim their independence and live life on their terms. The organization aims to continue its investment in research and development to further enhance its products, solidifying its commitment to its users and the broader medical and scientific community.